Infectious Diseases Trial of a Long-Acting Malaria Drug Injection Launches in RwandaGlobal Biodefense StaffNovember 5, 2026
CBRNE Radiation Countermeasure Entolimod Clears Mouse Safety Study, Moves to Survival TestGlobal Biodefense StaffNovember 3, 2026
Medical Countermeasures UK Commits £33.2 Million to Eight Vaccine Projects Targeting Ebola, Marburg, Plague and Other Epidemic ThreatsGlobal Biodefense StaffOctober 18, 2026
New Tuberculosis Drug Regimen Will Move to Landmark Phase 3 Trial Antimicrobial Resistance April 28, 2014 …
Rutgers Awarded $26M to Lead Development of New Antibiotics Antimicrobial Resistance April 28, 2014 …
Novel Agent for Tamiflu-Resistant pH1N1 Influenza Virus Discovered Medical Countermeasures April 24, 2014 …
Researchers Discover Possible New Target to Attack Flu Virus Medical Countermeasures April 13, 2014 …
Notable Contracts: DTRA Small Molecule Countermeasures Research Medical Countermeasures April 10, 2014 …
Rapid, Broad Countermeasures Sought Against Mystery Infections Medical Countermeasures April 8, 2014 …
Pharmocogenomics Has Not Fulfilled Its Promise to Developing Countries Medical Countermeasures April 4, 2014 …
UGA Awarded Grand Challenges Funding for Rotavirus Vaccine Research Medical Countermeasures April 1, 2014 …